Fact Check
New tool finds all CT health systems’ commercial prices are far higher than needed to cover expenses
According to a new tool, Connecticut hospitals would have needed commercial rates equal to 135% of Medicare levels in 2020 to cover their expenses, much higher than the US average of 114%. However, every health system in Connecticut charged well above that level, far more than needed to cover expenses. The National Academy for State…
Read MoreNew Cost Cap industry-driven committee gets going
Members of the Office of Health Strategy’s (OHS) latest committee to drive down the growth in Connecticut’s healthcare spending moved past their initial reluctance to engage in their November and December meetings. OHS expects the provider and insurer-dominated committee to agree on ways to reduce their own costs/profits. Hopefully, they do not also use the…
Read MoreFAQs on OHS’s Primary Care Roadmap
Download the FAQs here Connecticut’s Office of Health Strategy has developed a Primary Care Roadmap to support primary care in Connecticut. OHS is accepting public comment on the draft Roadmap until the close of business Friday, January 14th. To send comments, email Tina.Hyde@ct.gov and put “Primary Care Roadmap” in the subject line. You should get…
Read MoreAdvocacy Toolbox Addition — Social media for advocates
Social media has become an important tool for advocates. It can be a powerful way to connect with other people advocating on your issue and with elected officials. But it can be overwhelming, and a bit scary. We’ve added a new page to the CT Health Advocacy ToolBox distilling best practices for busy advocates to…
Read MoreOP-ED | Controversial New Alzheimer’s Drug Could Break the Bank
Alzheimer’s disease affects six million Americans, stealing memories years before it takes lives. Aduhelm, the first drug intended to treat the Alzheimer’s disease process rather than symptoms, was highly anticipated by patients and families. But it has disappointed on many levels. It isn’t clear that it actually helps patients and troubling side effects are common.…
Read MoreBOOK CLUB — The Right Price: A Value-Based Prescription for Drug Costs
For your summer reading. The Right Price: A Value-Based Prescription for Drug Costs offers the best explanation I’ve found of how drug costs are set, and how they should be. Using real-life patient stories, the authors give a balanced and comprehensive look at fair and reasonable pricing for a product that epitomizes market failure. The…
Read MoreANALYSIS | Who In Health Care Made Money on COVID?
Many COVID heroes who put their lives at risk or died caring for others. We all owe healthcare providers, scientists, public health professionals, and other frontline workers a huge debt of gratitude. But the healthcare industries did just fine. Four of the ten companies that profited most during the pandemic are in healthcare. Read more
Read MoreGovernor’s consultant report recommendations for Medicaid savings are baseless
It’s not in the headlines but the biggest source of potential savings, $200 million, proposed by the Governor’s controversial report from Boston Consulting Group (BCG) to save money in state government to is to go back to failed Medicaid financial risk models. There are two problems with the proposal. First, the financial risk models don’t…
Read MoreCTNJ: If The COVID Vaccine Is Free For Patients, Who Is Paying For It?
Federal law ensures the COVID vaccine will be provided to every American at no cost. So who is paying for it? Because it’s healthcare, the answer is complicated and we are all paying for it – mostly through taxes and a bit through our insurance premiums. Read more
Read MoreWhat does the public really think about a public option? Two polls, and we still don’t know
Dueling polls released this week find Connecticut residents either love the idea of a public health insurance option or they are not big fans. Not surprisingly, the polls are sponsored by groups with dueling agendas and they don’t give details or survey question wording. According to a poll released Monday by Comptroller Kevin Lembo, 71%…
Read More